P1451 Massive fatal venous thrombosis von De La Torre Carpente, M M, Redondo Bermejo, B, Perez Sanz, T M, Acuna Lorenzo, M A, Revilla Martinez, M I, Tapia Ballesteros, C, Guillem Ares, E S, Munoz Fuster, A C, Rollan Gomez, M J

Volltext

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation von PORTA, R, SANCHEZ-TORRES, J. M, CATOT, S, ISLA, D, PRADAS, A, GURPIDE, A, DE CASTRO, J, POLO, E, PUIG, T, TARON, M, COLOMER, R, ROSELL, R, PAZ-ARES, L, MASSUTI, B, REGUART, N, MAYO, C, LIANES, P, QUERALT, C, GUILLEM, V, SALINAS, P

Volltext

CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials von Segal, Neil H., Melero, Ignacio, Moreno, Victor, Steeghs, Neeltje, Marabelle, Aurelien, Rohrberg, Kristoffer, Rodriguez-Ruiz, Maria E., Eder, Joseph P., Eng, Cathy, Manji, Gulam A., Waterkamp, Daniel, Leutgeb, Barbara, Bouseida, Said, Flinn, Nick, Das Thakur, Meghna, Elze, Markus C., Koeppen, Hartmut, Jamois, Candice, Martin-Facklam, Meret, Lieu, Christopher H., Calvo, Emiliano, Paz-Ares, Luis, Tabernero, Josep, Argilés, Guillem

Volltext

Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy von Bellmunt, J, Paz-Ares, L, Cuello, M, Cecere, FL, Albiol, S, Guillem, V, Gallardo, E, Carles, J, Mendez, P, de la Cruz, JJ, Taron, M, Rosell, R, Baselga, J

Volltext

Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer von Rosell, Rafael, Moran, Teresa, Queralt, Cristina, Porta, Rut, Cardenal, Felipe, Camps, Carlos, Majem, Margarita, Lopez-Vivanco, Guillermo, Isla, Dolores, Provencio, Mariano, Insa, Amelia, Massuti, Bartomeu, Gonzalez-Larriba, Jose Luis, Paz-Ares, Luis, Bover, Isabel, Garcia-Campelo, Rosario, Moreno, Miguel Angel, Catot, Silvia, Rolfo, Christian, Reguart, Noemi, Palmero, Ramon, Sánchez, José Miguel, Bastus, Roman, Mayo, Clara, Bertran-Alamillo, Jordi, Molina, Miguel Angel, Sanchez, Jose Javier, Taron, Miquel

Volltext

Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the Urothelium von BELLMUNT, J, GUILLEM, V, BASTUS, R, CLIMENT, M. A, DE LA CRUZ, J. J, ALBANELL, J, BANUS, J. M, GALLARDO, E, DIAZ-RUBIO, E, CORTES-FUNES, H, BASELGA, J, PAZ-ARES, L, GONZALEZ-LARRIBA, J. L, CARIES, J, BATISTE-ALENTORN, E, SAENZ, A, LOPEZ-BREA, M, FONT, A, NOGUE, M

Volltext

108 Uncommon cardiac fatty distribution: a case report von Redondo Bermejo, B, De La Torre Carpente, M M, Munoz San Jose, J C, Escudero Caro, T, Acuna Lorenzo, M, Guillem Ares, E, Revilla Martinez, M, Rollan Gomez, M J

Volltext

Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine von Bellmunt, Joaquim, Albanell, Joan, Paz‐Ares, Luis, Climent, Miguel A., González‐Larriba, Jose L., Carles, Joan, de la Cruz, Juan J., Guillem, Vicente, Díaz‐Rubio, Eduardo, Cortés‐Funes, Hernan, Baselga, José

Volltext

Osteoarticular Cryptococcosis Successfully Treated with High-Dose Liposomal Amphotericin B Followed by Oral Fluconazole von Deus, Guillem, Gómez-Zorrilla, Silvia, Echeverria-Esnal, Daniel, Siverio, Ana, Güerri-Fernandez, Robert, Ares, Jesús, Campillo, Nuria, Letang, Emili, Knobel, Hernando, Grau, Santiago, Horcajada, Juan Pablo

Volltext

Phase Ia and Ib studies of the novel carcinoembryonic antigen (CEA) T-cell bispecific (CEA CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary eff... von Tabernero, Josep, Melero, Ignacio, Ros, Willeke, Argiles, Guillem, Marabelle, Aurelien, Rodriguez-Ruiz, Maria E., Albanell, Joan, Calvo, Emiliano, Moreno, Victor, Cleary, James M., Eder, Joseph Paul, Karanikas, Vaios, Bouseida, Said, Sandoval, Federico, Sabanes, Daniel, Sreckovic, Sasha, Hurwitz, Herbert, Paz-Ares, Luis G., Saro Suarez, Jose M., Segal, Neil Howard

Volltext

Social value of a quality-adjusted life year (QALY) in Spain: the point of view of oncologists von Camps-Herrero, C., Paz-Ares, L., Codes, M., López-López, R., Antón-Torres, A., Gascón-Vilaplana, P., Guillem-Porta, V., Carrato, A., Cruz-Hernández, J. J., Caballero-Díaz, C., Blasco-Cordellat, A., Moreno-Nogueira, J. A., Díaz-Rubio, E.

Volltext

Randomized phase III trial comparing adjuvant paclitaxel/gemcitabine/cisplatin (PGC) to observation in patients with resected invasive bladder cancer: Results of the Spanish Oncolo... von Paz-Ares, L. G., Solsona, E., Esteban, E., Saez, A., Gonzalez-Larriba, J., Anton, A., Hevia, M., de la Rosa, F., Guillem, V., Bellmunt, J.

Volltext

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group von Bellmunt, J, Guillem, V, Paz-Ares, L, González-Larriba, J L, Carles, J, Batiste-Alentorn, E, Sáenz, A, López-Brea, M, Font, A, Nogué, M, Bastús, R, Climent, M A, de la Cruz, J J, Albanell, J, Banús, J M, Gallardo, E, Diaz-Rubio, E, Cortés-Funes, H, Baselga, J

Volltext

656 RANDOMIZED PHASE III TRIAL COMPARING ADJUVANT PACLITAXEL/GEMCITABINE/CISPLATIN (PGC) TO OBSERVATION IN PATIENTS WITH RESECTED INVASIVE BLADDER CANCER: RESULTS OF THE SOGUG-GUO-... von Solsona, E, Paz-Ares, L, Fernandez, J.M, Hevia, M, Orsola, A, Morote, J, Bellmunt, J, De, La Rosa, F, Llorente, C, Donas, Jl, Guillem, V, Cozar, J.M, Ballesteros, P, Javaloyas, J, Carbonero, J, Burgues, J.P, Rodríguez, Molina, J, Gutierrez, J.L, García, D

Volltext

Diarrhea by Clostridium difficile von Prieto De Paula, J M, Villamandos Nicás, V, Sanz de la Fuente, H, Guillem Ares, E

Volltext